Gerrit Dingeldein

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

Akin Atmaca, S-E. Al-Batran, Dominique Werner et al. · British Journal of Cancer · 2013 · 34 citations · Full text

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Katharina Lisenko, Gerrit Dingeldein, Martin Cremer et al. · BMC Cancer · 2017 · 27 citations · Full text

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial

K. Elias, Hartmut Goldschmidt, Kaya Miah et al. · The Lancet Haematology · 2024 · 17 citations · Full text